In a groundbreaking effort, a team of scientists has introduced a flagship AI dataset from a study investigating biomarkers and environmental factors potentially influencing the development of type 2 diabetes.The studyās participants include both those without diabetes and individuals at various stages of the disease, and early findings suggest a complex array of insights distinct from prior research, according to a report published in Nature Metabolism.
āWeāre seeing data that supports heterogeneity among type 2 diabetes patientsāmeaning that people arenāt all facing the same condition. Thanks to the large, detailed datasets weāre gathering, researchers will be able to examine this diversity more closely,ā said Dr. Cecilia Lee, professor of ophthalmology at the University of Washington School of Medicine, US.
For instance, data from custom environmental sensors placed in participantsā homes reveal a clear association between disease progression and exposure to fine particulate pollutants.
The data also encompass survey responses, depression scales, eye-imaging scans, and traditional measurements of glucose and other biological indicators.
āAll these data are intended to be mined by AI for new insights on risks, preventive strategies, and pathways linking disease and health,ā the authors noted.
